News Quantified

OMER – omeros corporation (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

Sagimet Biosciences Announces Appointment of Andreas Grauer, MD, as Chief Medical Officer [Yahoo! Finance]

CMS Assigns Permanent Reimbursement J-Code for YARTEMLEA® (narsoplimab-wuug)

Omeros (OMER) was upgraded by Zacks Research from "hold" to "strong-buy".

Omeros (OMER) was upgraded by Wall Street Zen from "sell" to "hold".

Omeros: Making The Bull Case On Q4 Earnings, Ahead Of Key Q1 Commercial Updates [Seeking Alpha]

14.4%

BEAT

26.1%

BEAT

7.0%

BEAT

Form 10-K OMEROS CORP For: Dec 31

Form 8-K OMEROS CORP For: Mar 31

Form SCHEDULE 13G/A OMEROS CORP Filed by: VANGUARD GROUP INC

Form 4 OMEROS CORP For: Feb 18 Filed by: Demopulos Gregory A MD

Form SCHEDULE 13G OMEROS CORP Filed by: VANGUARD GROUP INC

Top News Gainers

3/2 Omeros Corporation Reports Updated Results from Narsoplimab HSCT-TMA Clinical Trial and Highlights from Recent Clinical and CMC Meetings with FDA 55.4%

3/31 Omeros Co. (NASDAQ: OMER) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $12.00 price target on the stock. 17.3%

5/10 Omeros Co. (NASDAQ: OMER) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. 13.6%

8/8 Q2/2019 6/30/2019 EPS -0.290 ZacksConsensus -0.450 ActVsEst 0.160 - Beat 11.9%

10/28 Omeros Corporation Initiates BLA Submission for Narsoplimab for the Treatment of HSCT-TMA 6.2%

8/5 Omeros Corporation to Announce Second Quarter 2019 Financial Results on August 8, 2019 6.0%

2/4 Omeros Co. (NASDAQ: OMER) was downgraded by analysts at BidaskClub from a "sell" rating to a "strong sell" rating. 4.9%

11/4 Omeros Corporation Announces Publication of Study Results on the Impact of OMIDRIA on Opioid Use and Pain 4.6%

11/19 Omeros Presents New GPR174 Immuno-oncology Data Today at the American Association for Cancer Research Conference in Boston 4.6%

8/12 Omeros Co. (NASDAQ: OMER) was given a new $32.00 price target on by analysts at Maxim Group. They now have a "buy" rating on the stock. 4.2%

Top News Decliners

12/4 Omeros Co. (NASDAQ: OMER) had its "hold" rating re-affirmed by analysts at Needham & Company LLC. -12.8%

5/6 Omeros Corporation to Announce First Quarter 2019 Financial Results on May 9, 2019 -9.3%

3/10 Omeros Co. (NASDAQ: OMER) was upgraded by analysts at ValuEngine from a "hold" rating to a "buy" rating. -8.7%

1/17 Omeros Co. (NASDAQ: OMER) was upgraded by analysts at BidaskClub from a "strong sell" rating to a "sell" rating. -7.8%

5/23 Omeros (OMER) Presents At UBS Global Healthcare Conference - Slideshow [Seeking Alpha] -5.9%

3/6 Omeros Co. (NASDAQ: OMER) was upgraded by analysts at BidaskClub from a "sell" rating to a "hold" rating. -5.7%

3/12 Omeros Co. (NASDAQ: OMER) was downgraded by analysts at BidaskClub from a "hold" rating to a "sell" rating. -5.7%

10/30 Omeros Co. (NASDAQ: OMER) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. -5.4%

2/25 Omeros Co. (NASDAQ: OMER) was upgraded by analysts at BidaskClub from a "strong sell" rating to a "sell" rating. -5.3%

12/27 Omeros Co. (NASDAQ: OMER) was upgraded by analysts at BidaskClub from a "strong sell" rating to a "sell" rating. -4.7%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day